Patterns of care for adults with newly diagnosed malignant glioma

JAMA

Volumn 293, Issue 5, 2005, Pages 557-564

  Chang, Susan M ^a   Parney, Ian F ^a   Huang, Wei ^b   Anderson, Frederick A ^b   Asher, Anthony L ^c   Bernstein, Mark ^d   Lillehei, Kevin O ^e   Brem, Henry ^f   Berger, Mitchel S ^a   Laws, Edward R ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c CAROLINA NEUROSURGERY AND SPINE ASSOCIATES   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF COLORADO   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CORTICOSTEROID; DALTEPARIN; HEPARIN; NITROSOUREA; TEMOZOLOMIDE;

ALTERNATIVE MEDICINE; ARTICLE; BRAIN MAPPING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY; CLINICAL FEATURE; CRANIOTOMY; DIABETES MELLITUS; ELECTRODIAGNOSIS; EVIDENCE BASED MEDICINE; FEMALE; GLIOBLASTOMA; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 19944432413     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.5.557     Document Type: Article

References (37)

1. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neurooncology. 2002;4:278-299.
2. Devaux BC, O'Fallon JR, Kelly PJ. Resection, biopsy, and survival in malignant glial neoplasms: a retrospective study of clinical parameters, therapy, and outcome. J Neurosurg. 1993;78:767-775.
3. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95:190-198.
4. Laperriere N, Zuraw L, Cairncross G. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol. 2002;64:259-273.
5. Parney IF, Chang S. Current chemotherapy for glioblastoma. Cancer J. 2003;9:149-156.
6. Frappaz D, Chinot O, Bataillard A, et al. Summary version of the standards, options and recommendations for the management of adult patients with intracranial glioma (2002). Br J Cancer. 2003;89(suppl 1):S73-S83.
7. Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;54:1886-1893.
8. Laws ER, Parney IF, Huang W, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg. 2003;99:467-473.
9. Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery. 2004;54:358-366.
10. Anderson FA Jr; and the Glioma Outcomes Project Advisory Board. The Glioma Outcomes Project: a resource for measuring and improving glioma outcomes. Neurosurg Focus. 1998;4:Article 8.
11. Karnofsky D, Abelman W, Craver L, Burchenal J. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer. 1948;1:634-656.
12. Chang S, Parney IF, McDermott M, et al. Perioperative complications and neurological outcome of first versus second craniotomy among patients enrolled in the Glioma Outcomes (GO) Project. J Neurosurg. 2003;98:1175-1181.
13. Chang SM, Barker FG II, Schmidt MH, et al. Clinical trial participation among patients enrolled in the Glioma Outcomes Project. Cancer. 2002;94:2681-2687.
14. Chen P, Aldape K, Wiencke JK, et al. Ethnicity delineates different genetic pathways in malignant glioma. Cancer Res. 2001;61:3949-3954.
15. McDermott MW, Krouwer HG, Asai A, Ito S, Hoshino T, Prados MD. A comparison of CT contrast enhancement and BUDR labeling indices in moderately and highly anaplastic astrocytomas of the cerebral hemispheres. Can J Neurol Sci. 1992;19:34-39.
16. Cascino GD. Epilepsy and brain tumors: implications for treatment. Epilepsia. 1990;31(suppl 3):S37-S44.
17. Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology. 1993;43:1678-1683.
18. McKeran RO, Thomas DGT. The clinical study of glioblastomas. In: Graham DL, ed. Brain Tumors: Scientific Basis, Clinical Investigation and Current Therapy. Baltimore, Md: Johns Hopkins University Press; 1990:194-230.
19. Sawaya R. Extent of resection in malignant gliomas: a critical summary. J Neurooncol. 1999;42:303-305.
20. Fine HA, Dear KBG, Loeffler JS, Black PM, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 1993;71:2585-2597.
21. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet. 2002;359:1011-1018.
22. Westphal M, Hilt DC, Bortey E, et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neurooncology. 2003;5:79-88.
23. Stupp R, Dietrich PY, Ostermann Kraljevic S, et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol. 2002;20:1375-1382.
24. Stupp R, Mason WP, Van Den Bent MJ, et al. Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM): conclusive results of a randomized phase III trial by the EORTC Brain and RT Groups and NCIC Clinical Trials Group. Paper presented at: American Society of Clinical Oncology 40th Annual Meeting; June 5-8, 2004; New Orleans, La.
25. Marras LC, Geerts WH, Perry JR. The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer. 2000;89:640-646.
26. Agnelli G, Piovella F, Buoncristiani P, et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med. 1998;339:80-85.
27. Nurmohamed MT, van Riel AM, Henkens CM, et al. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemost. 1996;75:233-238.
28. Dickinson LD, Miller LD, Patel CP, Gupta SK. Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery. 1998;43:1074-1081.
29. Galicich JH, French LA, Melby JC. Use of dexamethasone in the treatment of cerebral edema associated with brain tumors. Lancet. 1961;81:46-53.
30. Wen PY, Marks PW. Medical management of patients with brain tumors. Curr Opin Oncol. 2002;14:299-307.
31. Vecht CJ, Hovestadt A, Verbiest HB, van Vliet JJ, van Putten WL. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day. Neurology. 1994;44:675-680.
32. Kaibara T, Saunders JK, Sutherland GR. Advances in mobile intraoperative magnetic resonance imaging. Neurosurgery. 2000;47:131-137.
33. Matz PG, Cobbs C, Berger MS. Intraoperative cortical mapping as a guide to the surgical resection of gliomas. J Neurooncol. 1999;42:233-245.
34. Taylor MD, Bernstein M. Awake craniotomy with brain mapping as the routine surgical approach to treating patients with supratentorial intraaxial tumors: a prospective trial of 200 cases. J Neurosurg. 1999;90:35-41.
35. Bernstein M, Al-Anazi AR, Kucharczyk W, Manninen P, Bronskill M, Henkelman M. Brain tumor surgery with the Toronto open magnetic resonance imaging system: preliminary results for 36 patients and analysis of advantages, disadvantages, and future prospects. Neurosurgery. 2000;46:900-907.
36. Cowan JA Jr, Dimick JB, Leveque JC, Thompson BG, Upchurch GR Jr, Hoff JT. The impact of provider volume on mortality after intracranial tumor resection. Neurosurgery. 2003;52:48-53.
37. Long DM, Gordon T, Bowman H, et al. Outcome and cost of craniotomy performed to treat tumors in regional academic referral centers. Neurosurgery. 2003;52:1056-1063.